Anupriya Kulkarni

Anupriya Kulkarni started their work experience as a Graduate Trainee at the National Institute of Virology from April 2008 to July 2009. Anupriya then pursued their PhD at McGill University from January 2010 to March 2016. After that, they worked as a Postdoctoral Research Fellow at Massachusetts General Hospital from May 2016 to August 2021, during which they also held the role of Clinical Scientist in Biomarker Discovery from August 2018 to August 2021. Anupriya then joined Voyager Therapeutics, Inc. as a Scientist-II in Translational Medicine, Gene Therapy, and Biomarker Development from August 2021 to December 2022. Currently, Anupriya is working at Voyager Therapeutics, Inc. as a Senior Scientist-I, responsible for translational medicine, project management, and biomarker development.

Anupriya Kulkarni has an impressive education history. Anupriya completed their Bachelor of Science degree in Microbiology and Immunology at Savitribai Phule Pune University from 2004 to 2007. Anupriya then pursued a Master of Science degree in the same field at the same university, which they completed from 2007 to 2009. Building on their foundational knowledge, Anupriya went on to obtain a PhD in Biochemical Virology at McGill University from 2010 to 2015.